A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate cancer in 2010, and another was approved in 2015 for melanoma. Since then, ...

When Beatrice Dionigi was in medical school 15 years ago, she was taught that colon cancer—long known as a "silent killer" ...

Bristol Myers Squibb (BMS) has shared positive overall survival (OS) results from a late-stage study of its Opdivo (nivolumab) combination in non-small cell lung cancer (NSCLC).

Rising air pollution, changes in hormone levels, immune system imbalances and longer life expectancy are increasing the risk of lung cancer in women who have never touched a cigarette.

Candel Therapeutics' lead candidate CAN-2409 shows promising results in several indications. Find out why I rate CADL stock ...

During a live event, Alexander I. Spira, MD, PhD, and participants NGS testing practices and the rationale behind their ...

The most common form of lung cancer is primarily found in non-smokers, a new study reveals. Doctors react to the surprising ...

Cardiff Oncology's Onvansertib shows promise in treating RAS-mutated cancers, especially mCRC. See why I rate CRDF stock as a ...

Stanford scientists have identified 380 key genetic variants that significantly influence cancer development, filtering ...

CT imaging of patients entering lung cancer treatment identified a high prevalence of atherosclerosis, according to data ...